CHI Insight Pharma Reports
Advances Reports offer:
- Current information and analysis of R&D technologies, therapeutic markets, and critical business issues.
- Analysis of the probability of success for various applications of each technology.
- Interviews with key personnel in companies at the forefront of technological advances.
- Competitive insight on the business strategies and activities of key companies.
21 Reports from CHI Insight Pharma Reports
-
The Development of Therapeutic Monoclonal Antibody Products
...of disease. Sales of monoclonal antibody products have grown from approximately $50 billion in 2010 to almost $90 billion in 2015, an approximately 1.8‑fold increase and represent approximately 58% of biopharmaceutical sales. As more and ... Read More
-
Commercializing Novel IVDs: A Comprehensive Manual for Success
...test to diagnose a common autoimmune disorder, but you’re unsure of which regulatory pathway to pursue? The process of developing a successful in vitro diagnostic (IVD) relies on the expertise of a diverse group of ... Read More
-
Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes
...we focused on the major classes of cancer immunotherapy drugs that were then emerging from academic and corporate research: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies. This new report includes an updated discussion ... Read More
-
Combination Antibody Therapy for Cancer Treatment Overview
...sales, and if their performance has not been the unalloyed triumph that was foreseen at their inception, they have, at least in some instances, produced impressive gains in patient response. Today they are one of ... Read More
-
Gene Therapy: Moving Toward Commercialization
...therapy programs that are aimed at commercialization, and the companies that are carrying out these programs. A major theme of this report is whether gene therapy can attain commercial success by the early-to-mid 2020s, which ... Read More
-
Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and Lean Biomanufacturing System
...a more reactive and dynamic biomanufacturing approach than is the current industry standard. Biomanufacturing is common practice in the life sciences industry and has been continually developed and improved for the last two decades. However, ... Read More
-
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
...(karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development. ... Read More
-
Marketing to Life Scientists: A Best Practice Guide for Marketers
...the right time. Not to burst anyone’s bubble, but it won’t be getting easier any time soon. Social media’s rapid adoption in the workplace has opened countless avenues to reach potential customers. The digital age ... Read More
-
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management
...A major drawback of the tissue-based approach centers on the need for invasive surgical procedures in sample collection, which in a great many instances preclude following the progression or regression of disease during therapy. In ... Read More
-
Vaccines: The End of Illness Overview
...efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part of the target pathogen have been longstanding attributes of vaccines. Today, vaccine technology is undergoing ... Read More
-
The Human Microbiome: Biomedical Implications and Birth of a Market - Overview
...evolution of microbiome research and its growth in the commercial market. Specific areas of study include microbial ecology, systems biology, diet, diagnostics, contributions in health and disease, and infectious disease. Microbiota have become a center ... Read More
-
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
...dry) and devling into Anti-VEGF therapies in chapter 2. Further providing substantial weight to this report, several companies were interviewed on their approach to targeting wet and dry AMD, thier strategies for seeking alternative therapeutic ... Read More
-
Biomarkers in Alzheimer's Disease
...Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the ... Read More
-
Biomarkers in Parkinson's Disease
...Neurodegenerative Disorders, this report focuses on the Parkinson’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing ... Read More
-
Biomarkers in Amyotrophic Lateral Sclerosis
...a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With ... Read More
-
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
...development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there are many techniques used to track neurodegenerative disease progression, this report will ... Read More
-
Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria
...covers evolutionary growth of antibiotic resistant bacteria with a focus in research aspects, commercial aspects, market aspects, and trends in antibiotic resistance. Antibiotic resistance has a historical presence in the big pharma industry (documentation of ... Read More
-
Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks Overview
...it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding nature and ability to affect ... Read More
-
Vaccines: The End of Illness Overview
...efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part of the target pathogen have been longstanding attributes of vaccines. Today, vaccine technology is undergoing ... Read More
-
MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview
...it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding nature and ability to affect ... Read More
-
Molecular Diagnostic Market and Testing
...and clinicians in the cancer and prenatal space. This report focuses on market background of the areas that are covered, including lung, breast, thyroid and blood cancers (specifically leukemia and lymphoma), as well as pre-conception ... Read More
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook